Human insulin analogue aspart premix 50 per insulin ans 50 per insulin protamine aspart suspension
Other · awarded
Key facts
- Closing date: 23 Jul 2026
- Status: awarded
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
Commercial terms
- Make in India (MII): No
- MSE preference: No
1 tender document(s) available — sign up to download.